Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Infections | 10 | 2019 | 363 | 2.950 |
Why?
|
| Puerto Rico | 22 | 2024 | 1376 | 1.910 |
Why?
|
| Anus Neoplasms | 3 | 2023 | 43 | 1.790 |
Why?
|
| Papillomaviridae | 5 | 2019 | 136 | 1.600 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2024 | 350 | 1.470 |
Why?
|
| Early Detection of Cancer | 5 | 2023 | 428 | 1.040 |
Why?
|
| Cervix Uteri | 2 | 2017 | 47 | 0.900 |
Why?
|
| HIV Infections | 4 | 2023 | 2535 | 0.780 |
Why?
|
| Vaginal Smears | 2 | 2012 | 62 | 0.700 |
Why?
|
| Adult | 18 | 2024 | 13458 | 0.620 |
Why?
|
| Female | 21 | 2024 | 24018 | 0.600 |
Why?
|
| Video Recording | 1 | 2019 | 40 | 0.600 |
Why?
|
| Anus Diseases | 2 | 2016 | 17 | 0.600 |
Why?
|
| Mouth | 2 | 2019 | 49 | 0.590 |
Why?
|
| Middle Aged | 15 | 2024 | 11819 | 0.570 |
Why?
|
| Young Adult | 12 | 2024 | 4936 | 0.570 |
Why?
|
| Alphapapillomavirus | 2 | 2014 | 30 | 0.550 |
Why?
|
| Periodontitis | 1 | 2018 | 56 | 0.540 |
Why?
|
| Anal Canal | 2 | 2019 | 32 | 0.530 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 3077 | 0.530 |
Why?
|
| Adolescent | 10 | 2024 | 5950 | 0.500 |
Why?
|
| Neoplasms | 2 | 2020 | 1341 | 0.500 |
Why?
|
| Genotype | 2 | 2016 | 796 | 0.490 |
Why?
|
| Humans | 23 | 2024 | 42163 | 0.480 |
Why?
|
| Antibodies, Viral | 1 | 2018 | 295 | 0.480 |
Why?
|
| Vaccination | 1 | 2018 | 332 | 0.480 |
Why?
|
| Risk Factors | 8 | 2020 | 3942 | 0.470 |
Why?
|
| Stomatitis | 1 | 2014 | 2 | 0.460 |
Why?
|
| Gastroenterology | 1 | 2013 | 8 | 0.420 |
Why?
|
| Medical Oncology | 1 | 2013 | 46 | 0.410 |
Why?
|
| Incidence | 4 | 2024 | 1054 | 0.400 |
Why?
|
| Health Promotion | 1 | 2019 | 691 | 0.400 |
Why?
|
| Receptor, erbB-2 | 2 | 2013 | 149 | 0.390 |
Why?
|
| Self Administration | 1 | 2013 | 67 | 0.390 |
Why?
|
| Specimen Handling | 1 | 2013 | 61 | 0.390 |
Why?
|
| Education, Medical | 1 | 2013 | 117 | 0.380 |
Why?
|
| Ambulatory Care | 1 | 2013 | 81 | 0.380 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2014 | 225 | 0.370 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 959 | 0.370 |
Why?
|
| Liver Diseases | 1 | 2011 | 34 | 0.350 |
Why?
|
| Registries | 3 | 2024 | 431 | 0.350 |
Why?
|
| Self Care | 1 | 2012 | 173 | 0.350 |
Why?
|
| Uterine Neoplasms | 1 | 2012 | 51 | 0.340 |
Why?
|
| Diabetes Complications | 1 | 2011 | 99 | 0.340 |
Why?
|
| Genetic Testing | 1 | 2011 | 90 | 0.340 |
Why?
|
| Prevalence | 5 | 2019 | 1597 | 0.340 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 1679 | 0.330 |
Why?
|
| DNA, Viral | 3 | 2017 | 323 | 0.310 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 211 | 0.300 |
Why?
|
| Endometrial Neoplasms | 1 | 2010 | 79 | 0.300 |
Why?
|
| Mass Screening | 1 | 2012 | 531 | 0.290 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2012 | 471 | 0.280 |
Why?
|
| Male | 10 | 2023 | 22779 | 0.270 |
Why?
|
| Aged | 6 | 2024 | 7982 | 0.270 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 825 | 0.260 |
Why?
|
| Odds Ratio | 2 | 2018 | 587 | 0.240 |
Why?
|
| Homosexuality, Male | 2 | 2023 | 483 | 0.240 |
Why?
|
| Cost of Illness | 2 | 2017 | 95 | 0.230 |
Why?
|
| Logistic Models | 2 | 2018 | 1001 | 0.220 |
Why?
|
| Sex Factors | 3 | 2018 | 1008 | 0.220 |
Why?
|
| Neoplasm Staging | 1 | 2024 | 366 | 0.200 |
Why?
|
| United States | 3 | 2021 | 5072 | 0.200 |
Why?
|
| Age Factors | 3 | 2018 | 1139 | 0.200 |
Why?
|
| Survival Analysis | 2 | 2014 | 362 | 0.190 |
Why?
|
| Comorbidity | 2 | 2014 | 725 | 0.180 |
Why?
|
| SEER Program | 2 | 2012 | 157 | 0.160 |
Why?
|
| Genitalia, Male | 1 | 2019 | 14 | 0.150 |
Why?
|
| Human papillomavirus 6 | 1 | 2018 | 1 | 0.140 |
Why?
|
| Human papillomavirus 11 | 1 | 2018 | 2 | 0.140 |
Why?
|
| Human papillomavirus 18 | 1 | 2018 | 6 | 0.140 |
Why?
|
| Seroepidemiologic Studies | 1 | 2018 | 71 | 0.140 |
Why?
|
| Human papillomavirus 16 | 1 | 2018 | 37 | 0.140 |
Why?
|
| Program Evaluation | 1 | 2019 | 358 | 0.140 |
Why?
|
| Condylomata Acuminata | 1 | 2017 | 6 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 456 | 0.130 |
Why?
|
| Papillomavirus Vaccines | 1 | 2018 | 168 | 0.120 |
Why?
|
| Sampling Studies | 1 | 2014 | 64 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2016 | 68 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1020 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2016 | 428 | 0.110 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 24 | 0.110 |
Why?
|
| Warts | 1 | 2013 | 5 | 0.110 |
Why?
|
| Sexual Partners | 1 | 2017 | 325 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 2803 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2016 | 1221 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 35 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2010 | 2485 | 0.100 |
Why?
|
| Uterine Cervical Diseases | 1 | 2013 | 14 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 236 | 0.100 |
Why?
|
| HIV Seropositivity | 1 | 2014 | 196 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2013 | 100 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 116 | 0.100 |
Why?
|
| Prisoners | 1 | 2014 | 95 | 0.100 |
Why?
|
| Receptors, Progesterone | 1 | 2013 | 90 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2013 | 141 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 177 | 0.090 |
Why?
|
| Probability | 1 | 2012 | 82 | 0.090 |
Why?
|
| Physicians | 1 | 2013 | 180 | 0.090 |
Why?
|
| Biotechnology | 1 | 2011 | 15 | 0.090 |
Why?
|
| Students, Medical | 1 | 2013 | 153 | 0.090 |
Why?
|
| Consumer Health Information | 1 | 2011 | 24 | 0.090 |
Why?
|
| Alcoholism | 1 | 2014 | 292 | 0.090 |
Why?
|
| Marketing | 1 | 2011 | 44 | 0.090 |
Why?
|
| Prognosis | 1 | 2013 | 850 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 532 | 0.080 |
Why?
|
| Sexual Behavior | 1 | 2014 | 634 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 234 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 599 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 638 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2014 | 641 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2011 | 541 | 0.070 |
Why?
|
| Body Weights and Measures | 1 | 2016 | 25 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 326 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 386 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 774 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 662 | 0.020 |
Why?
|
| Health Behavior | 1 | 2016 | 568 | 0.020 |
Why?
|